ECOLAB INC. (ECL) Insider Transactions
Explore official ownership filings, with every record linked to its source.
ECL · ECOLAB INC.
How to read this data ↗Recent reported activity
Purchases and sales count original non-derivative P and S rows. Awards, gifts, exercises, derivatives and amendments are shown separately and are not described as market purchases.
| Transaction / filed | Reporting owner(s) | Code / security | Quantity | Price as filed | Ownership | Source |
|---|---|---|---|---|---|---|
| 2026-06-30Filed 2026-07-02 | LARSON MICHAELDirectorFiling contextReported filing row; may be amended. Do not sum filings blindly. F1 Includes 28.40 shares acquired pursuant to a dividend reinvestment feature of the Ecolab Inc. 2001 Non-Employee Director Stock Option and Deferred Compensation Plan. References: F1 | A Award / grantCommon Stock · Non-derivative | 130.18A | 0 | Direct | Form 4 ↗0001098825-26-000010 |
| 2026-06-11Filed 2026-06-15 | Clark Benjamin M.Officer · EVP - Global Supply ChainFiling contextReported filing row; may be amended. Do not sum filings blindly. F1 This transaction was executed in multiple trades at prices ranging from $263.800 to $263.840, inclusive. The price reported above reflects the weighted average purchase price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. References: F1 | P Purchase (market/private)Common Stock · Non-derivative | 1,000A | 263.831 | Direct | Form 4 ↗0002082984-26-000002 |
| 2026-06-10Filed 2026-06-11 | Doukeris Michel DDirectorFiling contextReported filing row; may be amended. Do not sum filings blindly. F1 This transaction was executed in multiple trades at prices ranging from $257.97 to $258.00, inclusive. The price reported above reflects the weighted average purchase price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. References: F1 | P Purchase (market/private)Common Stock · Non-derivative | 7,750A | 258 | Direct | Form 4 ↗0002058857-26-000008 |
| 2026-06-09Filed 2026-06-10 | Brown Darrell ROfficer · Co-COO - Global MarketsFiling contextReported filing row; may be amended. Do not sum filings blindly. F1 This transaction was executed in multiple trades at prices ranging from $260.80 to $261.06, inclusive. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. F2 The option became exercisable, on a cumulative basis, as to one-third of the option shares (excluding any fractional portion less than one share), on each of the first and second anniversaries of the date of grant and as to the remaining shares on the third anniversary of the date of grant. The date listed in the "Date Exercisable" column represents the first anniversary date of the grant. References: F2 | M Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 10,000D | 0 | Direct | Form 4 ↗0001727287-26-000007 |
| 2026-06-09Filed 2026-06-10 | Brown Darrell ROfficer · Co-COO - Global MarketsFiling contextReported filing row; may be amended. Do not sum filings blindly. F1 This transaction was executed in multiple trades at prices ranging from $260.80 to $261.06, inclusive. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. F2 The option became exercisable, on a cumulative basis, as to one-third of the option shares (excluding any fractional portion less than one share), on each of the first and second anniversaries of the date of grant and as to the remaining shares on the third anniversary of the date of grant. The date listed in the "Date Exercisable" column represents the first anniversary date of the grant. References: F1 | S Sale (market/private)Common Stock · Non-derivative | 10,000D | 260.887 | Direct | Form 4 ↗0001727287-26-000007 |
| 2026-06-09Filed 2026-06-10 | Brown Darrell ROfficer · Co-COO - Global MarketsFiling contextReported filing row; may be amended. Do not sum filings blindly. F1 This transaction was executed in multiple trades at prices ranging from $260.80 to $261.06, inclusive. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. F2 The option became exercisable, on a cumulative basis, as to one-third of the option shares (excluding any fractional portion less than one share), on each of the first and second anniversaries of the date of grant and as to the remaining shares on the third anniversary of the date of grant. The date listed in the "Date Exercisable" column represents the first anniversary date of the grant. References: | M Exercise / conversionCommon Stock · Non-derivative | 10,000A | 117.73 | Direct | Form 4 ↗0001727287-26-000007 |
| 2026-05-27Filed 2026-05-27 | Vautrinot Suzanne MDirectorFiling contextReported filing row; may be amended. Do not sum filings blindly. F1 Reflects the reporting person's payment of the exercise price for a stock option issued in accordance with Rule 16b-3 by delivering or withholding shares of Ecolab common stock. F2 The option became exercisable, on a cumulative basis, as to 25% of the option shares (excluding any fractional portion less than one share), on the last day of each of the first, second and third three-month periods following its date of grant and as to the remaining shares on the last day of the fourth three-month period following its date of grant. The date listed in the Date Exercisable column represents the first vesting date. References: | S Sale (market/private)Common Stock · Non-derivative | 1,004D | 264.98 | Direct | Form 4 ↗0001589791-26-000011 |
| 2026-05-22Filed 2026-05-27 | Vautrinot Suzanne MDirectorFiling contextReported filing row; may be amended. Do not sum filings blindly. F1 Reflects the reporting person's payment of the exercise price for a stock option issued in accordance with Rule 16b-3 by delivering or withholding shares of Ecolab common stock. F2 The option became exercisable, on a cumulative basis, as to 25% of the option shares (excluding any fractional portion less than one share), on the last day of each of the first, second and third three-month periods following its date of grant and as to the remaining shares on the last day of the fourth three-month period following its date of grant. The date listed in the Date Exercisable column represents the first vesting date. References: F2 | M Exercise / conversionNon-Employee Stock Option (Right to Buy) · Derivative | 2,000D | 0 | Direct | Form 4 ↗0001589791-26-000011 |
| 2026-05-22Filed 2026-05-27 | Vautrinot Suzanne MDirectorFiling contextReported filing row; may be amended. Do not sum filings blindly. F1 Reflects the reporting person's payment of the exercise price for a stock option issued in accordance with Rule 16b-3 by delivering or withholding shares of Ecolab common stock. F2 The option became exercisable, on a cumulative basis, as to 25% of the option shares (excluding any fractional portion less than one share), on the last day of each of the first, second and third three-month periods following its date of grant and as to the remaining shares on the last day of the fourth three-month period following its date of grant. The date listed in the Date Exercisable column represents the first vesting date. References: F1 | F WithholdingCommon Stock · Non-derivative | 996D | 252.267 | Direct | Form 4 ↗0001589791-26-000011 |
| 2026-05-22Filed 2026-05-27 | Vautrinot Suzanne MDirectorFiling contextReported filing row; may be amended. Do not sum filings blindly. F1 Reflects the reporting person's payment of the exercise price for a stock option issued in accordance with Rule 16b-3 by delivering or withholding shares of Ecolab common stock. F2 The option became exercisable, on a cumulative basis, as to 25% of the option shares (excluding any fractional portion less than one share), on the last day of each of the first, second and third three-month periods following its date of grant and as to the remaining shares on the last day of the fourth three-month period following its date of grant. The date listed in the Date Exercisable column represents the first vesting date. References: | M Exercise / conversionCommon Stock · Non-derivative | 2,000A | 125.665 | Direct | Form 4 ↗0001589791-26-000011 |
| 2026-05-15Filed 2026-05-19 | Doukeris Michel DDirectorFiling contextReported filing row; may be amended. Do not sum filings blindly. F1 The option will become exercisable, on a cumulative basis, as to 25% of the option shares (excluding any fractional portion less than one share), on the last day of each of the first, second and third three-month periods following its date of grant and as to the remaining shares on the earlier of the last day of the fourth three-month period following its date of grant or the company's next annual meeting date; provided, however, that if a Change in Control of the Company (as that term is defined in the Ecolab Inc. 2001 Non-Employee Director Stock Option and Deferred Compensation Plan) will occur, then the option will become immediately exercisable in full. The date listed in the Date Exercisable column represents the first vesting date. References: F1 | A Award / grantNon-Employee Director Stock Option (Right to Buy) · Derivative | 732A | 0 | Direct | Form 4 ↗0002058857-26-000006 |
| 2026-05-15Filed 2026-05-19 | Gross Marion K.DirectorFiling contextReported filing row; may be amended. Do not sum filings blindly. F1 The option will become exercisable, on a cumulative basis, as to 25% of the option shares (excluding any fractional portion less than one share), on the last day of each of the first, second and third three-month periods following its date of grant and as to the remaining shares on the earlier of the last day of the fourth three-month period following its date of grant or the company's next annual meeting date; provided, however, that if a Change in Control of the Company (as that term is defined in the Ecolab Inc. 2001 Non-Employee Director Stock Option and Deferred Compensation Plan) will occur, then the option will become immediately exercisable in full. The date listed in the Date Exercisable column represents the first vesting date. References: F1 | A Award / grantNon-Employee Director Stock Option (Right to Buy) · Derivative | 732A | 0 | Direct | Form 4 ↗0001942810-26-000006 |
| 2026-05-15Filed 2026-05-19 | Althoff JudsonDirectorFiling contextReported filing row; may be amended. Do not sum filings blindly. F1 The option will become exercisable, on a cumulative basis, as to 25% of the option shares (excluding any fractional portion less than one share), on the last day of each of the first, second and third three-month periods following its date of grant and as to the remaining shares on the earlier of the last day of the fourth three-month period following its date of grant or the company's next annual meeting date; provided, however, that if a Change in Control of the Company (as that term is defined in the Ecolab Inc. 2001 Non-Employee Director Stock Option and Deferred Compensation Plan) will occur, then the option will become immediately exercisable in full. The date listed in the Date Exercisable column represents the first vesting date. References: F1 | A Award / grantNon-Employee Director Stock Option (Right to Buy) · Derivative | 732A | 0 | Direct | Form 4 ↗0001868758-26-000006 |
| 2026-05-15Filed 2026-05-19 | Vautrinot Suzanne MDirectorFiling contextReported filing row; may be amended. Do not sum filings blindly. F1 The option will become exercisable, on a cumulative basis, as to 25% of the option shares (excluding any fractional portion less than one share), on the last day of each of the first, second and third three-month periods following its date of grant and as to the remaining shares on the earlier of the last day of the fourth three-month period following its date of grant or the company's next annual meeting date; provided, however, that if a Change in Control of the Company (as that term is defined in the Ecolab Inc. 2001 Non-Employee Director Stock Option and Deferred Compensation Plan) will occur, then the option will become immediately exercisable in full. The date listed in the Date Exercisable column represents the first vesting date. References: F1 | A Award / grantNon-Employee Director Stock Option (Right to Buy) · Derivative | 732A | 0 | Direct | Form 4 ↗0001589791-26-000007 |
| 2026-05-15Filed 2026-05-19 | McKibben Tracy BDirectorFiling contextReported filing row; may be amended. Do not sum filings blindly. F1 The option will become exercisable, on a cumulative basis, as to 25% of the option shares (excluding any fractional portion less than one share), on the last day of each of the first, second and third three-month periods following its date of grant and as to the remaining shares on the earlier of the last day of the fourth three-month period following its date of grant or the company's next annual meeting date; provided, however, that if a Change in Control of the Company (as that term is defined in the Ecolab Inc. 2001 Non-Employee Director Stock Option and Deferred Compensation Plan) will occur, then the option will become immediately exercisable in full. The date listed in the Date Exercisable column represents the first vesting date. References: F1 | A Award / grantNon-Employee Director Stock Option (Right to Buy) · Derivative | 732A | 0 | Direct | Form 4 ↗0001584119-26-000017 |
| 2026-05-15Filed 2026-05-19 | MacLennan DavidDirectorFiling contextReported filing row; may be amended. Do not sum filings blindly. F1 The option will become exercisable, on a cumulative basis, as to 25% of the option shares (excluding any fractional portion less than one share), on the last day of each of the first, second and third three-month periods following its date of grant and as to the remaining shares on the earlier of the last day of the fourth three-month period following its date of grant or the company's next annual meeting date; provided, however, that if a Change in Control of the Company (as that term is defined in the Ecolab Inc. 2001 Non-Employee Director Stock Option and Deferred Compensation Plan) will occur, then the option will become immediately exercisable in full. The date listed in the Date Exercisable column represents the first vesting date. References: F1 | A Award / grantNon-Employee Director Stock Option (Right to Buy) · Derivative | 732A | 0 | Direct | Form 4 ↗0001498535-26-000010 |
| 2026-05-15Filed 2026-05-19 | Green Eric MarkDirectorFiling contextReported filing row; may be amended. Do not sum filings blindly. F1 The option will become exercisable, on a cumulative basis, as to 25% of the option shares (excluding any fractional portion less than one share), on the last day of each of the first, second and third three-month periods following its date of grant and as to the remaining shares on the earlier of the last day of the fourth three-month period following its date of grant or the company's next annual meeting date; provided, however, that if a Change in Control of the Company (as that term is defined in the Ecolab Inc. 2001 Non-Employee Director Stock Option and Deferred Compensation Plan) will occur, then the option will become immediately exercisable in full. The date listed in the Date Exercisable column represents the first vesting date. References: F1 | A Award / grantNon-Employee Director Stock Option (Right to Buy) · Derivative | 732A | 0 | Direct | Form 4 ↗0001336007-26-000006 |
| 2026-05-15Filed 2026-05-19 | Ballard Shari LDirectorFiling contextReported filing row; may be amended. Do not sum filings blindly. F1 The option will become exercisable, on a cumulative basis, as to 25% of the option shares (excluding any fractional portion less than one share), on the last day of each of the first, second and third three-month periods following its date of grant and as to the remaining shares on the earlier of the last day of the fourth three-month period following its date of grant or the company's next annual meeting date; provided, however, that if a Change in Control of the Company (as that term is defined in the Ecolab Inc. 2001 Non-Employee Director Stock Option and Deferred Compensation Plan) will occur, then the option will become immediately exercisable in full. The date listed in the Date Exercisable column represents the first vesting date. References: F1 | A Award / grantNon-Employee Director Stock Option (Right to Buy) · Derivative | 732A | 0 | Direct | Form 4 ↗0001311220-26-000006 |
| 2026-05-15Filed 2026-05-19 | Whalen JulieDirectorFiling contextReported filing row; may be amended. Do not sum filings blindly. F1 The option will become exercisable, on a cumulative basis, as to 25% of the option shares (excluding any fractional portion less than one share), on the last day of each of the first, second and third three-month periods following its date of grant and as to the remaining shares on the earlier of the last day of the fourth three-month period following its date of grant or the company's next annual meeting date; provided, however, that if a Change in Control of the Company (as that term is defined in the Ecolab Inc. 2001 Non-Employee Director Stock Option and Deferred Compensation Plan) will occur, then the option will become immediately exercisable in full. The date listed in the Date Exercisable column represents the first vesting date. References: F1 | A Award / grantNon-Employee Director Stock Option · Derivative | 537A | 0 | Direct | Form 4 ↗0001274281-26-000006 |
| 2026-05-15Filed 2026-05-19 | Whalen JulieDirectorFiling contextReported filing row; may be amended. Do not sum filings blindly. F1 The option will become exercisable, on a cumulative basis, as to 25% of the option shares (excluding any fractional portion less than one share), on the last day of each of the first, second and third three-month periods following its date of grant and as to the remaining shares on the earlier of the last day of the fourth three-month period following its date of grant or the company's next annual meeting date; provided, however, that if a Change in Control of the Company (as that term is defined in the Ecolab Inc. 2001 Non-Employee Director Stock Option and Deferred Compensation Plan) will occur, then the option will become immediately exercisable in full. The date listed in the Date Exercisable column represents the first vesting date. References: F1 | A Award / grantNon-Employee Director Stock Option (Right to Buy) · Derivative | 732A | 0 | Direct | Form 4 ↗0001274281-26-000006 |
| 2026-05-15Filed 2026-05-19 | ZILLMER JOHN JDirectorFiling contextReported filing row; may be amended. Do not sum filings blindly. F1 The option will become exercisable, on a cumulative basis, as to 25% of the option shares (excluding any fractional portion less than one share), on the last day of each of the first, second and third three-month periods following its date of grant and as to the remaining shares on the earlier of the last day of the fourth three-month period following its date of grant or the company's next annual meeting date; provided, however, that if a Change in Control of the Company (as that term is defined in the Ecolab Inc. 2001 Non-Employee Director Stock Option and Deferred Compensation Plan) will occur, then the option will become immediately exercisable in full. The date listed in the Date Exercisable column represents the first vesting date. References: F1 | A Award / grantNon-Employee Director Stock Option (Right to Buy) · Derivative | 732A | 0 | Direct | Form 4 ↗0001188262-26-000007 |
| 2026-05-15Filed 2026-05-19 | NOWELL LIONEL L IIIDirectorFiling contextReported filing row; may be amended. Do not sum filings blindly. F1 The option will become exercisable, on a cumulative basis, as to 25% of the option shares (excluding any fractional portion less than one share), on the last day of each of the first, second and third three-month periods following its date of grant and as to the remaining shares on the earlier of the last day of the fourth three-month period following its date of grant or the company's next annual meeting date; provided, however, that if a Change in Control of the Company (as that term is defined in the Ecolab Inc. 2001 Non-Employee Director Stock Option and Deferred Compensation Plan) will occur, then the option will become immediately exercisable in full. The date listed in the Date Exercisable column represents the first vesting date. References: F1 | A Award / grantNon-Employee Director Stock Option (Right to Buy) · Derivative | 732A | 0 | Direct | Form 4 ↗0001180436-26-000006 |
| 2026-05-15Filed 2026-05-19 | LARSON MICHAELDirectorFiling contextReported filing row; may be amended. Do not sum filings blindly. F1 The option will become exercisable, on a cumulative basis, as to 25% of the option shares (excluding any fractional portion less than one share), on the last day of each of the first, second and third three-month periods following its date of grant and as to the remaining shares on the earlier of the last day of the fourth three-month period following its date of grant or the company's next annual meeting date; provided, however, that if a Change in Control of the Company (as that term is defined in the Ecolab Inc. 2001 Non-Employee Director Stock Option and Deferred Compensation Plan) will occur, then the option will become immediately exercisable in full. The date listed in the Date Exercisable column represents the first vesting date. References: F1 | A Award / grantNon-Employee Director Stock Option (Right to Buy) · Derivative | 732A | 0 | Direct | Form 4 ↗0001098825-26-000008 |
| 2026-05-13Filed 2026-05-14 | MacLennan DavidDirectorFiling contextReported filing row; may be amended. Do not sum filings blindly. References: | P Purchase (market/private)Common Stock · Non-derivative | 1,000A | 250.65 | Direct | Form 4 ↗0001498535-26-000008 |
Imported instruments only. Joint owners do not multiply transactions. Amendments are separate filing rows, not additional trades. No aggregate trade totals are implied.